Mirna Therapeutics Company Profile (NASDAQ:MIRN)

About Mirna Therapeutics

Mirna Therapeutics logoMirna Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of micro ribonucleic acid (RNA)-based oncology therapeutics. The Company is developing mimics of naturally occurring microRNAs that are designed to restore the tumor suppressor activity and aid appropriate anti-tumor immune response. This approach is known as microRNA replacement therapy. Its lead product candidate, MRX34, a mimic of naturally occurring microRNA-34 (miR-34) encapsulated in a liposomal nanoparticle formulation, has demonstrated clinical proof of concept as a single agent in its ongoing Phase I clinical trial. The Company's RNA molecules function as natural microRNAs when they enter human cells. These RNA molecules, which it calls microRNA mimics, may be used to replace those tumor suppressor microRNAs that are lost, or under expressed, in cancer cells. Its other preclinical product candidates include miR-215, miR-101, miR-16 and let-7.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MIRN
  • CUSIP:
Key Metrics:
  • Previous Close: $1.97
  • 50 Day Moving Average: $2.73
  • 200 Day Moving Average: $4.00
  • 52-Week Range: $1.82 - $11.01
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.16
  • P/E Growth: 0.00
  • Market Cap: $41.04M
  • Outstanding Shares: 20,835,000
Profitability:
  • Return on Equity: -64.21%
  • Return on Assets: -37.80%
Debt:
  • Current Ratio: 20.13%
  • Quick Ratio: 20.13%
Additional Links:
Companies Related to Mirna Therapeutics:

Analyst Ratings

Consensus Ratings for Mirna Therapeutics (NASDAQ:MIRN) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $4.10 (108.12% upside)

Analysts' Ratings History for Mirna Therapeutics (NASDAQ:MIRN)
Show:
DateFirmActionRatingPrice TargetDetails
9/23/2016HC WainwrightDowngradeBuy -> Neutral$6.00 -> $2.00View Rating Details
9/22/2016Citigroup Inc.Lower Price TargetNeutral$4.50 -> $2.00View Rating Details
9/21/2016Leerink SwannReiterated RatingHold -> Neutral$4.00 -> $1.50View Rating Details
9/21/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
9/21/2016Cantor FitzgeraldDowngradeBuy -> Hold$14.00 -> $2.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Mirna Therapeutics (NASDAQ:MIRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016        
11/13/2015Q315($82.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mirna Therapeutics (NASDAQ:MIRN)
Current Year EPS Consensus Estimate: $-1.27 EPS
Next Year EPS Consensus Estimate: $-1.7 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.43)($0.43)($0.43)
Q2 20162($0.50)($0.43)($0.47)
Q3 20162($0.38)($0.29)($0.34)
Q4 20162($0.59)($0.29)($0.44)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mirna Therapeutics (NASDAQ:MIRN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirna Therapeutics (NASDAQ:MIRN)
Insider Ownership Percentage: 18.60%
Institutional Ownership Percentage: 30.55%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2015Michael PowellDirectorBuy857,142$7.00$5,999,994.00View SEC Filing  
10/6/2015Pfizer Incmajor shareholderBuy714,285$7.00$4,999,995.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mirna Therapeutics (NASDAQ:MIRN)
DateHeadline
4-traders.com logoMIRNA THERAPEUTICS, INC. : Other Events (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - September 29 at 6:07 PM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Other Events (NASDAQ:MIRN)
biz.yahoo.com - September 29 at 6:07 PM
News IconNew study: Global metastatic hepatocellular carcinoma (HCC) pipeline 2016 market research (NASDAQ:MIRN)
www.whatech.com - September 27 at 6:02 PM
News IconHere's Why Mirna Therapeutics Inc Shares Are Falling 24% (NASDAQ:MIRN)
magseriesusa.net - September 24 at 10:34 AM
News IconMirna Therapeutics' (MIRN) Neutral Rating Reaffirmed at Leerink Swann (NASDAQ:MIRN)
thelakeandeswave.com - September 24 at 10:34 AM
stockhouse.com logoMirna's Murky Clinical Strategy Leaves HC Wainwright Hesitant (NASDAQ:MIRN)
www.stockhouse.com - September 23 at 10:50 AM
streetinsider.com logoMirna Therapeutics (MIRN) Halts Clinical Study of MRX34 Following Severe Adverse Events (NASDAQ:MIRN)
www.streetinsider.com - September 22 at 5:53 PM
News IconToxicity troubles halt Mirna's phase I trial of microRNA mimic MRX34 (NASDAQ:MIRN)
www.bioworld.com - September 22 at 5:53 PM
businesswire.com logoMirna Therapeutics Halts Phase 1 Clinical Study of MRX34 (NASDAQ:MIRN)
www.businesswire.com - September 22 at 5:53 PM
finance.yahoo.com logoMirna Hits a New Low After Halting Clinical Trial (NASDAQ:MIRN)
finance.yahoo.com - September 21 at 5:50 PM
finance.yahoo.com logoMirna Therapeutics (MIRN) Is in Oversold Territory: What's Next? (NASDAQ:MIRN)
finance.yahoo.com - September 13 at 10:58 AM
stockhouse.com logoH.C. Wainwright Initiates Mirna At Buy, Sees 135% Upside (NASDAQ:MIRN)
www.stockhouse.com - September 12 at 5:54 PM
publicnow.com logoMirna Therapeutics to Participate in Two Healthcare Investor Conferences in September (NASDAQ:MIRN)
www.publicnow.com - August 31 at 11:04 AM
finance.yahoo.com logoValue Screeners Identify Cheap Company Stocks (NASDAQ:MIRN)
finance.yahoo.com - August 29 at 6:03 PM
finance.yahoo.com logoMirna Therapeutics downgraded by Leerink Partners (NASDAQ:MIRN)
finance.yahoo.com - August 16 at 6:20 PM
reuters.com logoBRIEF-Mirna Therapeutics qtrly net loss attributable to common stockholders $5.64 mln (NASDAQ:MIRN)
www.reuters.com - August 15 at 8:24 AM
News IconMirna Therapeutics Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:MIRN)
ih.advfn.com - August 15 at 8:24 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - August 15 at 8:24 AM
sg.finance.yahoo.com logoMirna Therapeutics reports 2Q loss (NASDAQ:MIRN)
sg.finance.yahoo.com - August 15 at 8:23 AM
businesswire.com logomiRagen Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:MIRN)
www.businesswire.com - August 11 at 9:21 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MIRN)
biz.yahoo.com - July 6 at 5:19 PM
publicnow.com logoMirna Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:MIRN)
www.publicnow.com - July 5 at 7:21 AM
finance.yahoo.com logoMirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:MIRN)
finance.yahoo.com - July 5 at 7:00 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - July 1 at 6:11 PM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a V (NASDAQ:MIRN)
biz.yahoo.com - June 30 at 5:30 PM
publicnow.com logoMirna Therapeutics Appoints Perry Nisen, M.D., Ph.D., to Its Board of Directors (NASDAQ:MIRN)
www.publicnow.com - June 30 at 7:21 AM
capitalcube.com logoMirna Therapeutics, Inc. :MIRN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:MIRN)
www.capitalcube.com - June 8 at 6:07 PM
publicnow.com logoMirna Therapeutics Announces Clinical Data on its Lead microRNA Therapeutic Presented at ASCO (NASDAQ:MIRN)
www.publicnow.com - June 6 at 12:28 PM
bizjournals.com logoAustin-area Public Companies list (NASDAQ:MIRN)
www.bizjournals.com - June 3 at 8:58 AM
marketwired.com logoMarina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French (NASDAQ:MIRN)
www.marketwired.com - June 2 at 6:32 PM
tmcnet.com logomiRagen Therapeutics Receives ALS Association Grant to Advance the Development of MRG-107 (NASDAQ:MIRN)
www.tmcnet.com - June 2 at 9:04 AM
News IconMirna Therapeutics, Inc. (MIRN) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:MIRN)
www.sharetrading.news - May 30 at 7:20 PM
sg.finance.yahoo.com logoMirna Therapeutics reports 1Q loss (NASDAQ:MIRN)
sg.finance.yahoo.com - May 12 at 6:52 PM
publicnow.com logoMirna Therapeutics Reports First Quarter 2016 Financial Results and Program Updates (NASDAQ:MIRN)
www.publicnow.com - May 12 at 5:27 PM
marketwired.com logoMarina Biotech Terminates Negotiations for Sale of Its Nucleic Acid Therapeutic Assets (NASDAQ:MIRN)
www.marketwired.com - May 3 at 11:35 AM
4-traders.com logoMIRNA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - April 27 at 12:31 PM
publicnow.com logoMirna Therapeutics Appoints Vincent J. O'Neill, M.D., as Chief Medical Officer (NASDAQ:MIRN)
www.publicnow.com - April 25 at 7:25 AM
finance.yahoo.com logoMirna Therapeutics Appoints Vincent J. O’Neill, M.D., as Chief Medical Officer (NASDAQ:MIRN)
finance.yahoo.com - April 25 at 7:00 AM
News IconMARINA BIOTECH CMN (OTCMKTS:MRNA) Shorts Decreased by 45.93% After Short Covering (NASDAQ:MIRN)
www.bibeypost.com - April 22 at 12:25 PM
finance.yahoo.com logo8:52 am Mirna Therapeutics announces results in 2 data presentations at the annual meeting of the American Association for Cancer Research (NASDAQ:MIRN)
finance.yahoo.com - April 20 at 8:52 AM
publicnow.com logoMirna Therapeutics Announces Data Presentations at the Annual Meeting of the American Association for Cancer Research (NASDAQ:MIRN)
www.publicnow.com - April 20 at 8:51 AM
benzinga.com logoAnalyst Highlights Regulus Therapeutics' 'Disruptive 2016 Catalysts' (NASDAQ:MIRN)
www.benzinga.com - April 13 at 11:41 AM
finance.yahoo.com logoMIRNA THERAPEUTICS, INC. Financials (NASDAQ:MIRN)
finance.yahoo.com - April 2 at 1:04 PM
finance.yahoo.com logoMarina Biotech Provides 2015 Year-End Financials and Update (NASDAQ:MIRN)
finance.yahoo.com - March 31 at 10:48 AM
bizjournals.com logoAustin biotech firm's IPO for cancer drugs may not be as big as originally thought (NASDAQ:MIRN)
www.bizjournals.com - March 30 at 10:52 AM
4-traders.com logoMIRNA THERAPEUTICS : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MIRN)
www.4-traders.com - March 30 at 10:52 AM
seekingalpha.com logoMirna Therapeutics's (MIRN) CEO Paul Lammers on Q4 2015 Results - Earnings Call Transcript (NASDAQ:MIRN)
seekingalpha.com - March 30 at 10:52 AM
biz.yahoo.com logoMIRNA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report (NASDAQ:MIRN)
biz.yahoo.com - March 30 at 6:21 AM
publicnow.com logoMirna Therapeutics Provides Operational Update and Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2015 (NASDAQ:MIRN)
www.publicnow.com - March 29 at 4:24 PM
4-traders.com logoMIRNA THERAPEUTICS : to Host Conference Call and Webcast of Fourth Quarter and.. (NASDAQ:MIRN)
www.4-traders.com - March 22 at 10:50 AM

Social

Mirna Therapeutics (NASDAQ:MIRN) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff